Long Noncoding RNA LINC00460 Promotes Hepatocellular Carcinoma Progression via Regulation of miR-342-3p/AGR2 Axis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
• Long non-coding RNA (lncRNA) LINC00460 is implicated as an oncogene in various cancers.
• The specific role and mechanism of LINC00460 in HCC remain largely uncharacterized.

Purpose of the Study:

• To investigate the clinical relevance and biological function of LINC00460 in HCC.
• To elucidate the underlying molecular mechanism by which LINC00460 influences HCC progression.
• To assess LINC00460 as a potential therapeutic target for HCC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess LINC00460 expression in HCC tissues and cell lines.
• Cell Counting Kit-8 (CCK-8) and Transwell assays to evaluate HCC cell proliferation, migration, and invasion.
• RNA pull-down and luciferase assays to confirm the interaction between LINC00460 and miR-342-3p.
• Xenograft models to validate the in vivo role of LINC00460 in HCC progression.

Main Results:

• LINC00460 expression was significantly upregulated in HCC tissues and cell lines, correlating positively with HCC progression.
• LINC00460 overexpression enhanced HCC cell proliferation, migration, and invasion.
• LINC00460 directly binds to and represses miR-342-3p, leading to elevated AGR2 expression.

Conclusions:

• This study reveals the clinical significance, functional role, and regulatory mechanism of LINC00460 in HCC.
• LINC00460 promotes HCC progression by increasing AGR2 levels through sponging miR-342-3p.
• LINC00460 represents a promising therapeutic target for hepatocellular carcinoma.